Wikipedia -WSS

Wikipedia

author：fashion 2025-09-28 18:30:51 - browse：1

Silhouetted hands passing money. -- health business coverage from STAT — Adobe

The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem: Faulty technology systems are leading to people paying more for care and coverage than they should be.

The Centers for Medicare and Medicaid Services fined three different Medicare Advantage plans this month, each one getting dinged differently for the way they overcharged their members. The fines are minuscule for the insurance companies — roughly equivalent to some pennies under a couch cushion — but they could serve as warnings for companies to clean up their compliance and IT infrastructure before regulators knock on their doors again.

“Just the knowledge that CMS will be back one day and that you better have this fixed, I think, does have a sentinel effect,” said Philip Legendy, an attorney at Ballard Spahr who represents Medicare Advantage plans. “And if you’re doing it over and over, it could be viewed as intentional.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Chemotherapy drug shortage eases slightly but still widespread

WSS

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Senate panel eyes new effort on drug shortages

3 questions for the future of Biden's cancer moonshot

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

He's a Nobel laureate. Critics say he was misleading on Covid

explore

Wikipedia

leisure time

Walensky prepares to leave CDC — and Congress — behind

A new nitrogen execution bill also undermines medical licensing

What does generative AI mean for health care? We asked experts

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Walensky prepares to leave CDC — and Congress — behind

Senate panel eyes new effort on drug shortages

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

PBM reform efforts get punted in Congress

Anesthesiologist group: stop taking Ozempic before surgery

Dario to buy mental health app maker Twill in cash and stock deal

hotspot

Liquid biopsy for lung cancer is launched by Delfi

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

3 questions for the future of Biden's cancer moonshot

Community Health Systems hospitals under DOJ investigation

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

The Harvard botanist who searched for psychedelics in the Amazon

leisure time

focus

leisure time

leisure time